Live feed
Filing
SC 13G
SC 13G0001019056-22-000268·Rosalind Advisors, Inc.
Schedule 13G ownership disclosure
Trevi Therapeutics Inc
Security class unavailable · CUSIP: 89532M101
Event date: 2022-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,185,664
- Percent of class
- 8.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-22-000268
- Form type
- SC 13G
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Mar 09, 2022
- Reporting period
- Feb 28, 2022
- Description
- Schedule 13G beneficial ownership